Richard J. Berman
Sits on 5 boards. Overboarded · 5 public boards Last updated September 27, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 15 years
- Director since
- 2023
15 years of board service in total across 5 boards, counting each seat separately. Longest: BioVie Inc., 3 years.
BioVie Inc.
Director
CryoPort Inc.
Director
Context Therapeutics Inc.
Director
Sidus Space Inc.
Director
Celularity Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2024 | Celularity Inc. | Grant or award | +67,416 | — | — |
| Nov 20, 2024 | BioVie Inc. | Grant or award | +34,200 | — | — |
| May 17, 2024 | CryoPort Inc. | Grant or award | +12,845 | — | — |
| May 15, 2024 | CryoPort Inc. | Open-market sale | −8,105 | $13.41 | $108,688 |
| Nov 9, 2023 | BioVie Inc. | Grant or award | +51,830 | — | — |
| Aug 22, 2023 | BioVie Inc. | Open-market sale | −10,805 | $3.50 | $37,818 |
| Jun 7, 2023 | BioVie Inc. | Open-market sale | −5,984 | $5.81 | $34,767 |
| May 22, 2023 | BioVie Inc. | Open-market sale | −5,000 | $6.50 | $32,500 |
| May 12, 2023 | CryoPort Inc. | Grant or award | +8,105 | — | — |
| May 11, 2023 | CryoPort Inc. | Open-market sale | −7,203 | $21.51 | $154,937 |
| Mar 28, 2023 | BioVie Inc. | Open-market sale | −5,000 | $8.52 | $42,600 |
| Mar 28, 2023 | BioVie Inc. | Open-market sale | −2,613 | $8.52 | $22,263 |
| Mar 27, 2023 | BioVie Inc. | Open-market sale | −3,371 | $8.52 | $28,721 |
| Nov 23, 2022 | BioVie Inc. | Grant or award | +43,578 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.